Related Experiment Video

Updated: Jul 5, 2025

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm
06:53

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Published on: July 23, 2020

5.6K

Impact of patient motion on parametric PET imaging

Alessia Artesani1,2, Joyce van Sluis3, Johannes H van Snick3

  • 1Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Italy. alessia.artesani@hunimed.eu.

European Journal of Nuclear Medicine and Molecular Imaging
|January 14, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph
05:32

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph

Published on: February 21, 2025

291
MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

11.8K

Related Experiment Videos

Last Updated: Jul 5, 2025

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm
06:53

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Published on: July 23, 2020

5.6K
Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph
05:32

Retrospective Cardiac Gating with A Prototype Small-Animal X-ray Computed Tomograph

Published on: February 21, 2025

291
MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

11.8K

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

122
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
122

Articles linked to this work by shared authors, journal, and citation graph.

Lutetium-177-PSMA-617 in Oligo-metastatic Hormone-sensitive Prostate Cancer (BULLSEYE): A Trial Update.

European urology focus·2026

Context-dependent efficacy of fibroblast activation protein-targeted radionuclide therapy (FAP-TRT): the dual role of CAFs.

European journal of nuclear medicine and molecular imaging·2026

Subtype-Specific Metabolic Patterns in Staging Breast Cancer: Insights from Conventional and Parametric PET Radiomics.

Cancers·2026

Effects of dose heterogeneity on response and toxicity after 90Y-SIRT for HCC.

European journal of nuclear medicine and molecular imaging·2026

Deep learning-based malignancy probability estimation of pulmonary nodules in PET/CT imaging.

European radiology·2026

Long vs. short axial field-of-view PET scanners for brain imaging: a phantom study.

Frontiers in nuclear medicine·2026

Total-body [11C]carfentanil PET: Liver-brain axis in methadone vs. buprenorphine treatment.

European journal of nuclear medicine and molecular imaging·2026

The potential of [18F]FDG PET/MRI for identifying pain sources in patients with diagnostically challenging chronic hip pain after total hip replacement.

European journal of nuclear medicine and molecular imaging·2026

Automated joint segmentation enables quantitative molecular imaging of degeneration with [¹⁸F]FDG and [¹⁸F]NaF PET/CT.

European journal of nuclear medicine and molecular imaging·2026

Digital [18F]FDG PET/CT as first-line diagnostic modality for cranial giant cell arteritis.

European journal of nuclear medicine and molecular imaging·2026

Transarterial radioembolisation combined with targeted therapy and immune checkpoint inhibitors in advanced hepatocellular carcinoma with portal vein tumour thrombus: efficacy, safety, and dosimetric analysis.

European journal of nuclear medicine and molecular imaging·2026

Deep learning-based PET/CT mixture-of-experts model for relapse risk stratification in relapsed/refractory classical hodgkin lymphoma: a multicenter study.

European journal of nuclear medicine and molecular imaging·2026

First UV-Based Strategies Integrating Whiteness, Greenness, and Blueness Appraisals for Estimating Meloxicam and Tramadol Concurrently in Their Veterinary Mixture.

Archiv der Pharmazie·2026

Suspected amantadine-induced hypoglycaemia in a dog treated for chronic lumbosacral pain.

Veterinary anaesthesia and analgesia·2026

Population pharmacokinetic modeling of sulfamethoxazole, sulfadiazine and sulfadimethoxine combined with trimethoprim in calves.

Veterinary journal (London, England : 1997)·2026

Medetomidine-vatinoxan (Zenalpha) results in reduction of systolic function, blood pressure, and heart rate with prolongation of electrocardiographic intervals in healthy dogs.

Journal of the American Veterinary Medical Association·2026

Common Exotic Pet Intoxications.

The veterinary clinics of North America. Exotic animal practice·2026

Prognostic Value of [18F]FDG PET Combined with [68Ga]Ga-PSMA PET as Pretreatment Imaging in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with [177Lu]Lu-PSMA-617.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us